Compare Stocks

IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, Germany, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; collagen ELISAs for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides lyophilization services for making disposable medical device components; and custom fermentation and contract manufacturing services. It serves manufacturers of medical devices, quality control labs, low molecular weight heparin manufacturers, and academic research institutions. IBEX Technologies Inc. was incorporated in 1972 and is based in Montreal, Canada.

Nuveen Preferred Securities Income Fund is a closed-ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Spectrum Asset Management, Inc. It invests in the fixed income markets of the United States. The fund primarily invests in investment grade preferred debt securities, convertible debt securities, and convertible preferred securities that are rated BBB/Baa or better by S&P, Moody's, or Fitch. It was formerly known as Nuveen Quality Preferred Income Fund 2. Nuveen Preferred Securities Income Fund was formed on June 24, 2002 and is domiciled in the United States.

The Engine No. 1 Transform Supply Chain ETF (SUPP) is an exchange-traded fund. The fund's investment portfolio concentrates primarily on industrials equity. SUPP is an actively managed, high-conviction portfolio of US equities that are considered to be driving and benefiting from the supply chain transformation SUPP was launched on Feb 14, 2023 and is managed by Engine No. 1.